HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphoprotein (DSPP) cause dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by entrapping normal DSPP.

Abstract
Families with nonsyndromic dentinogenesis imperfecta (DGI) and the milder, dentin dysplasia (DD), have mutations in one allele of the dentin sialophosphoprotein (DSPP) gene. Because loss of a single Dspp allele in mice (and likely, humans) causes no dental phenotype, the mechanism(s) underling the dominant negative effects were investigated. DSPP mutations occur in three classes. (The first class, the mid-leader missense mutation, Y6D, was not investigated in this report.) All other 5′ mutations of DSPP result in changes/loss in the first three amino acids (isoleucine-proline-valine [IPV]) of mature DSPP or, for the A15V missense mutation, some retention of the hydrophobic leader sequence. All of this second class of mutations caused mutant DSPP to be retained in the rough endoplasmic reticulum (rER) of transfected HEK293 cells. Trafficking out of the rER by coexpressed normal DSPP was reduced in a dose-responsive manner, probably due to formation of Ca2+-dependent complexes with the retained mutant DSPP. IPV-like sequences begin many secreted Ca2+-binding proteins, and changing the third amino acid to the charged aspartate (D) in three other acidic proteins also caused increased rER accumulation. Both the leader-retaining A15V and the long string of hydrophobic amino acids resulting from all known frameshift mutations within the 3′-encoded Ca2+-binding repeat domain (third class of mutations) caused retention by association of the mutant proteins with rER membranes. More 5′ frameshift mutations result in longer mutant hydrophobic domains, but the milder phenotype, DD, probably due to lower effectiveness of the remaining, shorter Ca2+-binding domain in capturing normal DSPP protein within the rER. This study presents evidence of a shared underlying mechanism of capturing of normal DSPP by two different classes of DSPP mutations and offers an explanation for the mild (DD-II) versus severe (DGI-II and III) nonsyndromic dentin phenotypes. Evidence is also presented that many acidic, Ca2+-binding proteins may use the same IPV-like receptor/pathway for exiting the rER.
AuthorsZofia von Marschall, Seeun Mok, Matthew D Phillips, Dianalee A McKnight, Larry W Fisher
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (J Bone Miner Res) Vol. 27 Issue 6 Pg. 1309-21 (Jun 2012) ISSN: 1523-4681 [Electronic] United States
PMID22392858 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Copyright© 2012 American Society for Bone and Mineral Research.
Chemical References
  • Chromogranin A
  • Extracellular Matrix Proteins
  • Mutant Proteins
  • Phosphoproteins
  • Protein Sorting Signals
  • Recombinant Proteins
  • Sialoglycoproteins
  • dentin sialophosphoprotein
Topics
  • Amino Acid Motifs
  • Amino Acid Sequence
  • Animals
  • Blotting, Western
  • Chromogranin A (metabolism)
  • Dentin Dysplasia (genetics, metabolism)
  • Dentinogenesis Imperfecta (genetics, metabolism)
  • Endoplasmic Reticulum, Rough (metabolism)
  • Extracellular Matrix Proteins (chemistry, metabolism)
  • Frameshift Mutation (genetics)
  • Genes, Dominant (genetics)
  • HEK293 Cells
  • Humans
  • Intracellular Space (metabolism)
  • Mice
  • Microscopy, Confocal
  • Models, Biological
  • Molecular Sequence Data
  • Mutant Proteins (chemistry, classification, metabolism)
  • Phosphoproteins (chemistry, metabolism)
  • Protein Sorting Signals
  • Protein Transport
  • Recombinant Proteins (metabolism)
  • Sequence Deletion
  • Sialoglycoproteins (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: